[Hub]/) : Traits : Standing height : ← →

chr3:133,088,362-137,423,165

Best TWAS P=3.95e-31 · Best GWAS P=1.65e-32 conditioned to 1

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
116	YFS	Blood	MSL2	0.02	0.04	lasso	2	0.03	9.9e-11	-11.65	11.6	3.9e-31	-0.98	0.02	0.98	TRUE
129	The Cancer Genome Atlas	Glioblastoma Multiforme	CEP63	0.10	0.03	blup	49	0.04	2.5e-02	-8.46	9.7	2.1e-22	0.01	0.02	0.54	TRUE
35	GTEx	Breast Mammary Tissue (Male)	ANAPC13	0.44	0.36	lasso	6	0.25	1.5e-06	-8.43	9.2	2.3e-20	0.03	0.03	0.97	TRUE
100	GTEx	Thyroid	RP11-85F14.5	0.07	0.00	lasso	7	0.01	4.7e-02	5.50	-8.9	4.5e-19	0.52	0.12	0.17	TRUE
52	GTEx	Esophagus Mucosa	PPP2R3A	0.06	0.06	lasso	3	0.04	9.1e-04	-7.26	-7.4	9.8e-14	0.69	0.36	0.49	TRUE
4	CommonMind	Brain Pre-frontal Cortex	NCK1	0.05	0.00	blup	357	0.01	1.2e-02	7.16	-7.3	2.1e-13	0.32	0.69	0.05	TRUE
83	GTEx	Skin Sun Exposed Lower leg	ANAPC13	0.20	0.28	enet	24	0.32	9.4e-27	-8.41	7.1	1.0e-12	0.02	0.04	0.96	TRUE
50	GTEx	Colon Transverse	RP11-85F14.5	0.07	0.06	lasso	4	0.04	6.3e-03	7.09	-7.1	1.1e-12	0.18	0.42	0.20	TRUE
54	GTEx	Esophagus Mucosa	RYK	0.08	0.08	enet	3	0.05	1.8e-04	-7.01	-7.1	1.3e-12	-0.03	0.79	0.01	TRUE
146	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	MSL2	0.04	0.02	blup	35	0.01	1.9e-02	3.56	6.1	9.7e-10	-0.65	0.05	0.25	TRUE
132	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	MSL2	0.07	0.02	enet	6	0.03	1.7e-04	3.60	6.1	9.9e-10	-0.68	0.06	0.23	TRUE
109	METSIM	Adipose	IL20RB	0.15	0.00	bslmm	353	0.06	3.4e-09	3.04	-5.5	4.5e-08	0.25	0.10	0.60	TRUE
18	GTEx	Artery Coronary	SLC35G2	0.16	0.03	lasso	8	0.05	6.4e-03	-10.93	11.1	9.2e-29	-0.80	0.07	0.69	FALSE
70	GTEx	Muscle Skeletal	RP11-85F14.5	0.10	0.08	lasso	17	0.09	6.3e-09	7.06	-10.6	2.1e-26	0.52	0.50	0.50	FALSE
46	GTEx	Cells Transformed fibroblasts	RP11-85F14.5	0.10	0.08	enet	38	0.09	3.9e-07	7.15	-9.9	5.0e-23	0.47	0.82	0.16	FALSE
71	GTEx	Muscle Skeletal	RP11-731C17.2	0.15	0.12	lasso	16	0.12	3.8e-12	7.07	-9.8	8.0e-23	0.44	0.99	0.01	FALSE
128	The Cancer Genome Atlas	Glioblastoma Multiforme	ANAPC13	0.24	0.09	lasso	12	0.08	1.8e-03	-8.41	9.4	6.2e-21	0.01	0.02	0.72	FALSE
119	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	ANAPC13	0.08	0.12	blup	38	0.12	3.4e-10	-8.66	9.3	8.8e-21	0.02	0.01	0.99	FALSE
29	GTEx	Brain Cerebellum	RP11-731C17.2	0.31	0.05	enet	39	0.12	2.3e-04	7.07	-9.3	1.2e-20	0.39	0.27	0.29	FALSE
126	The Cancer Genome Atlas	Esophageal Carcinoma	ANAPC13	0.21	0.16	enet	16	0.18	1.7e-06	-8.40	9.3	1.9e-20	0.02	0.02	0.98	FALSE
141	The Cancer Genome Atlas	Brain Lower Grade Glioma	CEP63	0.04	0.05	blup	49	0.04	8.2e-06	-8.46	9.2	3.1e-20	0.01	0.03	0.97	FALSE
2	CommonMind	Brain Pre-frontal Cortex	CEP63	0.09	0.06	bslmm	502	0.07	1.4e-08	-8.42	9.0	2.0e-19	0.03	0.03	0.97	FALSE
3	CommonMind	Brain Pre-frontal Cortex	KY	0.10	0.09	bslmm	499	0.10	7.5e-12	-8.22	-8.9	3.9e-19	0.00	0.08	0.92	FALSE
97	GTEx	Thyroid	PPP2R3A	0.10	0.05	enet	18	0.06	1.3e-05	-7.28	-8.9	4.9e-19	0.75	0.05	0.95	FALSE
155	The Cancer Genome Atlas	Prostate Adenocarcinoma	CEP63	0.04	0.02	blup	49	0.03	5.9e-04	-8.46	8.9	5.2e-19	0.00	0.04	0.92	FALSE
86	GTEx	Skin Sun Exposed Lower leg	RP11-85F14.5	0.04	0.01	enet	9	0.03	2.8e-03	7.13	-8.9	5.4e-19	0.34	0.27	0.42	FALSE
95	GTEx	Testis	RP11-85F14.5	0.12	0.03	enet	28	0.02	3.8e-02	7.16	-8.9	5.6e-19	0.49	0.16	0.73	FALSE
148	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	ANAPC13	0.10	0.13	lasso	4	0.12	1.0e-08	-8.45	8.9	5.6e-19	0.02	0.02	0.98	FALSE
10	GTEx	Adipose Visceral Omentum	PPP2R3A	0.08	0.00	enet	17	0.00	3.0e-01	-9.62	-8.8	8.8e-19	0.67	0.10	0.54	FALSE
138	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	CEP63	0.24	0.12	blup	49	0.13	4.9e-08	-8.25	8.8	1.1e-18	-0.01	0.06	0.94	FALSE
112	NTR	Blood	EPHB1	0.05	0.02	lasso	7	0.02	7.3e-08	-7.96	8.8	1.8e-18	0.01	0.17	0.83	FALSE
5	CommonMind	Brain Pre-frontal Cortex	PPP2R3A	0.05	0.02	lasso	4	0.05	7.7e-07	-11.76	-8.8	2.2e-18	0.75	0.02	0.97	FALSE
164	The Cancer Genome Atlas	Thyroid Carcinoma	CEP63	0.15	0.07	blup	49	0.08	1.7e-08	-8.39	8.8	2.2e-18	0.01	0.04	0.96	FALSE
122	The Cancer Genome Atlas	Breast Invasive Carcinoma	CEP63	0.03	0.03	blup	49	0.04	2.7e-08	-8.42	8.7	2.3e-18	0.01	0.03	0.97	FALSE
49	GTEx	Colon Transverse	ANAPC13	0.31	0.39	lasso	3	0.38	1.8e-19	-8.43	8.7	3.2e-18	0.03	0.02	0.98	FALSE
149	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	CEP63	0.04	0.03	blup	49	0.04	1.5e-03	-8.38	8.6	6.1e-18	0.01	0.04	0.85	FALSE
87	GTEx	Small Intestine Terminal Ileum	ANAPC13	0.33	0.22	lasso	9	0.20	3.8e-05	-8.47	8.6	8.2e-18	0.02	0.03	0.94	FALSE
103	GTEx	Vagina	ANAPC13	0.43	0.28	enet	21	0.22	1.2e-05	-8.46	8.6	8.7e-18	0.02	0.03	0.96	FALSE
74	GTEx	Ovary	ANAPC13	0.22	0.23	enet	9	0.22	3.4e-06	-8.38	8.6	1.0e-17	0.01	0.03	0.96	FALSE
131	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	CEP63	0.07	0.07	blup	49	0.09	6.9e-10	-8.44	8.6	1.2e-17	0.01	0.03	0.97	FALSE
45	GTEx	Cells Transformed fibroblasts	CEP63	0.17	0.24	lasso	3	0.25	1.7e-18	-8.66	8.5	1.4e-17	0.03	0.02	0.98	FALSE
135	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	CEP63	0.04	0.07	lasso	4	0.06	3.1e-07	-8.47	8.5	1.7e-17	0.01	0.04	0.96	FALSE
58	GTEx	Esophagus Muscularis	ANAPC13	0.35	0.52	lasso	13	0.54	5.1e-38	-8.38	8.5	1.9e-17	0.02	0.03	0.97	FALSE
154	The Cancer Genome Atlas	Prostate Adenocarcinoma	ANAPC13	0.20	0.32	blup	38	0.33	6.8e-35	-8.39	8.5	1.9e-17	0.02	0.03	0.97	FALSE
41	GTEx	Cells EBV-transformed lymphocytes	ANAPC13	0.45	0.47	lasso	5	0.45	2.3e-16	-8.43	8.5	2.0e-17	0.03	0.03	0.97	FALSE
7	GTEx	Adipose Subcutaneous	ANAPC13	0.34	0.49	lasso	10	0.49	7.5e-45	-8.37	8.5	2.1e-17	0.02	0.04	0.96	FALSE
101	GTEx	Uterus	ANAPC13	0.52	0.39	lasso	3	0.36	4.0e-08	-8.54	8.5	2.2e-17	0.03	0.03	0.97	FALSE
17	GTEx	Artery Coronary	ANAPC13	0.56	0.56	lasso	7	0.54	4.2e-21	-8.41	8.5	2.3e-17	0.02	0.03	0.97	FALSE
72	GTEx	Nerve Tibial	ANAPC13	0.40	0.45	enet	15	0.46	1.1e-35	-8.39	8.5	2.3e-17	0.03	0.02	0.98	FALSE
111	NTR	Blood	CEP63	0.04	0.04	enet	18	0.04	3.6e-14	-8.41	8.5	2.4e-17	0.02	0.04	0.96	FALSE
56	GTEx	Esophagus Mucosa	CEP63	0.27	0.30	lasso	6	0.32	5.0e-22	-7.96	8.5	2.5e-17	0.01	0.05	0.95	FALSE
124	The Cancer Genome Atlas	Colon Adenocarcinoma	CEP63	0.07	0.12	lasso	3	0.11	5.3e-07	-8.66	8.5	2.5e-17	0.03	0.02	0.98	FALSE
107	METSIM	Adipose	ANAPC13	0.18	0.32	lasso	5	0.32	1.2e-49	-8.43	8.5	2.6e-17	0.02	0.04	0.96	FALSE
142	The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	ANAPC13	0.20	0.26	enet	17	0.24	1.1e-11	-8.40	8.5	2.6e-17	0.03	0.02	0.98	FALSE
24	GTEx	Brain Cerebellar Hemisphere	ANAPC13	0.30	0.20	lasso	3	0.19	1.4e-05	-8.38	8.5	2.7e-17	0.01	0.04	0.93	FALSE
64	GTEx	Liver	ANAPC13	0.37	0.40	lasso	7	0.39	5.8e-12	-8.39	8.4	3.0e-17	0.02	0.03	0.97	FALSE
53	GTEx	Esophagus Mucosa	ANAPC13	0.31	0.42	lasso	6	0.47	5.3e-35	-8.66	8.4	3.1e-17	0.02	0.02	0.98	FALSE
98	GTEx	Thyroid	ANAPC13	0.27	0.36	enet	17	0.36	5.7e-29	-8.39	8.4	3.1e-17	0.02	0.04	0.96	FALSE
69	GTEx	Muscle Skeletal	CEP63	0.12	0.14	lasso	4	0.13	2.2e-12	-8.66	8.4	3.2e-17	0.04	0.02	0.98	FALSE
102	GTEx	Uterus	CEP63	0.31	0.24	lasso	5	0.20	6.4e-05	-8.43	8.4	3.2e-17	0.03	0.03	0.94	FALSE
76	GTEx	Pancreas	CEP63	0.23	0.24	lasso	1	0.22	1.4e-09	-8.43	8.4	3.6e-17	0.03	0.03	0.97	FALSE
160	The Cancer Genome Atlas	Skin Cutaneous Melanoma	ANAPC13	0.15	0.10	lasso	10	0.10	1.4e-03	-8.42	8.4	3.7e-17	0.02	0.02	0.89	FALSE
159	The Cancer Genome Atlas	Soft Tissue Sarcoma	CEP63	0.08	0.06	blup	49	0.08	2.0e-05	-8.54	8.4	4.0e-17	0.02	0.03	0.96	FALSE
14	GTEx	Adrenal Gland	ANAPC13	0.40	0.48	lasso	7	0.48	2.4e-19	-8.38	8.4	4.1e-17	0.02	0.03	0.97	FALSE
27	GTEx	Brain Cerebellum	ANAPC13	0.15	0.13	lasso	5	0.12	2.0e-04	-8.46	8.4	4.1e-17	0.01	0.04	0.95	FALSE
161	The Cancer Genome Atlas	Stomach Adenocarcinoma	ANAPC13	0.19	0.21	lasso	2	0.21	5.7e-15	-8.41	8.4	4.2e-17	0.02	0.03	0.97	FALSE
68	GTEx	Muscle Skeletal	ANAPC13	0.26	0.37	lasso	5	0.38	6.2e-40	-8.37	8.4	4.5e-17	0.02	0.03	0.97	FALSE
75	GTEx	Pancreas	ANAPC13	0.45	0.50	lasso	3	0.50	6.6e-24	-8.43	8.4	4.5e-17	0.03	0.03	0.97	FALSE
19	GTEx	Artery Coronary	CEP63	0.22	0.30	lasso	5	0.29	1.8e-10	-8.39	8.4	4.7e-17	0.02	0.03	0.97	FALSE
158	The Cancer Genome Atlas	Soft Tissue Sarcoma	ANAPC13	0.05	0.05	lasso	1	0.04	1.4e-03	-8.39	8.4	4.7e-17	0.02	0.02	0.88	FALSE
88	GTEx	Spleen	ANAPC13	0.59	0.60	enet	20	0.63	2.6e-20	-8.38	8.4	4.9e-17	0.02	0.03	0.97	FALSE
121	The Cancer Genome Atlas	Breast Invasive Carcinoma	ANAPC13	0.10	0.21	lasso	3	0.21	9.2e-42	-8.37	8.4	5.1e-17	0.02	0.03	0.97	FALSE
65	GTEx	Lung	ANAPC13	0.33	0.50	lasso	8	0.49	5.2e-42	-8.37	8.4	5.2e-17	0.02	0.04	0.96	FALSE
11	GTEx	Adipose Visceral Omentum	ANAPC13	0.42	0.52	lasso	2	0.51	1.5e-30	-8.37	8.4	5.5e-17	0.02	0.04	0.96	FALSE
32	GTEx	Breast Mammary Tissue	ANAPC13	0.47	0.58	lasso	7	0.57	3.1e-35	-8.37	8.4	5.5e-17	0.02	0.04	0.96	FALSE
63	GTEx	Heart Left Ventricle	ANAPC13	0.22	0.23	lasso	3	0.22	5.3e-12	-8.38	8.4	5.5e-17	0.02	0.04	0.96	FALSE
12	GTEx	Adipose Visceral Omentum	CEP63	0.22	0.17	lasso	1	0.19	4.6e-10	-8.37	8.4	6.0e-17	0.02	0.03	0.97	FALSE
62	GTEx	Heart Atrial Appendage	ANAPC13	0.33	0.37	lasso	1	0.36	4.7e-17	-8.37	8.4	6.0e-17	0.02	0.04	0.96	FALSE
151	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	ANAPC13	0.35	0.53	lasso	9	0.53	1.3e-25	-8.41	8.4	6.3e-17	0.03	0.02	0.98	FALSE
38	GTEx	Breast Mammary Tissue (Female)	ANAPC13	0.41	0.53	lasso	8	0.50	2.8e-17	-8.37	8.3	7.8e-17	0.02	0.04	0.96	FALSE
145	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	ANAPC13	0.08	0.15	lasso	3	0.14	3.9e-16	-8.42	8.3	8.2e-17	0.02	0.03	0.97	FALSE
15	GTEx	Artery Aorta	ANAPC13	0.44	0.55	lasso	3	0.54	1.1e-34	-8.37	8.3	9.0e-17	0.02	0.04	0.96	FALSE
134	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	ANAPC13	0.21	0.36	enet	13	0.38	1.3e-44	-8.40	8.3	9.6e-17	0.03	0.03	0.97	FALSE
79	GTEx	Prostate	ANAPC13	0.61	0.50	lasso	10	0.50	2.3e-14	-8.43	8.3	1.0e-16	0.02	0.03	0.97	FALSE
90	GTEx	Stomach	PPP2R3A	0.08	0.02	lasso	4	0.05	1.9e-03	-9.62	8.3	1.0e-16	-0.78	0.10	0.82	FALSE
33	GTEx	Breast Mammary Tissue	CEP63	0.12	0.13	lasso	2	0.13	5.3e-07	-8.37	8.3	1.3e-16	0.01	0.03	0.97	FALSE
105	GTEx	Whole Blood	ANAPC13	0.09	0.10	lasso	4	0.08	1.2e-07	-8.37	8.3	1.4e-16	0.02	0.03	0.97	FALSE
36	GTEx	Breast Mammary Tissue (Male)	CEP63	0.05	-0.01	lasso	2	-0.01	5.5e-01	-8.25	8.2	1.6e-16	0.00	0.04	0.48	FALSE
21	GTEx	Artery Tibial	ANAPC13	0.42	0.54	lasso	6	0.54	8.9e-50	-8.41	8.2	1.7e-16	0.03	0.02	0.98	FALSE
99	GTEx	Thyroid	CEP63	0.05	0.06	lasso	3	0.05	1.1e-04	-7.88	8.2	2.0e-16	0.01	0.04	0.96	FALSE
113	YFS	Blood	ANAPC13	0.13	0.28	lasso	4	0.28	1.0e-92	-8.41	8.2	2.1e-16	0.02	0.04	0.96	FALSE
37	GTEx	Breast Mammary Tissue (Male)	RP11-85F14.5	0.08	0.12	lasso	1	0.06	1.6e-02	-8.21	-8.2	2.2e-16	0.63	0.04	0.56	FALSE
140	The Cancer Genome Atlas	Brain Lower Grade Glioma	ANAPC13	0.08	0.15	enet	9	0.14	1.2e-15	-8.41	8.2	2.2e-16	0.02	0.03	0.97	FALSE
91	GTEx	Stomach	ANAPC13	0.31	0.42	lasso	8	0.43	2.0e-22	-8.38	8.2	2.3e-16	0.02	0.04	0.96	FALSE
80	GTEx	Skin Not Sun Exposed Suprapubic	ANAPC13	0.15	0.14	lasso	7	0.14	7.3e-08	-7.88	8.2	2.8e-16	0.02	0.04	0.96	FALSE
108	METSIM	Adipose	CEP63	0.10	0.12	lasso	6	0.12	6.0e-17	-8.22	8.2	3.8e-16	0.01	0.06	0.94	FALSE
162	The Cancer Genome Atlas	Testicular Germ Cell Tumors	ANAPC13	0.23	0.07	blup	38	0.11	1.1e-04	-8.37	8.1	6.4e-16	0.01	0.02	0.98	FALSE
104	GTEx	Vagina	CEP63	0.31	0.03	enet	15	0.15	3.0e-04	6.80	8.1	6.5e-16	-0.01	0.04	0.86	FALSE
16	GTEx	Artery Aorta	CEP63	0.27	0.28	lasso	6	0.27	2.8e-15	-8.38	8.1	7.9e-16	0.03	0.03	0.97	FALSE
137	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	ANAPC13	0.16	0.21	lasso	3	0.22	8.4e-13	-8.54	8.0	1.2e-15	0.03	0.01	0.99	FALSE
143	The Cancer Genome Atlas	Lung Adenocarcinoma	ANAPC13	0.14	0.26	lasso	3	0.25	3.2e-29	-8.37	8.0	1.2e-15	0.03	0.03	0.97	FALSE
59	GTEx	Esophagus Muscularis	CEP63	0.27	0.32	lasso	5	0.32	5.3e-20	-8.38	8.0	1.3e-15	0.01	0.03	0.97	FALSE
48	GTEx	Colon Sigmoid	CEP63	0.17	0.20	lasso	5	0.18	8.2e-07	-8.43	8.0	1.5e-15	0.03	0.03	0.97	FALSE
8	GTEx	Adipose Subcutaneous	CEP63	0.20	0.20	enet	36	0.24	2.7e-19	-8.41	7.9	2.3e-15	0.01	0.02	0.98	FALSE
153	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	ANAPC13	0.24	0.14	blup	38	0.12	1.2e-05	-8.41	7.9	2.6e-15	0.02	0.02	0.97	FALSE
20	GTEx	Artery Tibial	PPP2R3A	0.07	0.07	lasso	2	0.05	1.5e-04	-7.46	-7.9	2.9e-15	0.71	0.52	0.17	FALSE
89	GTEx	Spleen	CEP63	0.33	0.31	lasso	10	0.25	4.4e-07	-8.38	7.9	2.9e-15	0.01	0.03	0.96	FALSE
39	GTEx	Breast Mammary Tissue (Female)	CEP63	0.14	0.15	lasso	2	0.17	7.5e-06	-7.88	7.9	3.3e-15	0.01	0.04	0.92	FALSE
130	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	ANAPC13	0.24	0.26	blup	38	0.26	8.3e-29	-8.66	7.9	3.3e-15	0.02	0.01	0.99	FALSE
1	CommonMind	Brain Pre-frontal Cortex	ANAPC13	0.09	0.10	bslmm	475	0.12	1.7e-14	-8.37	7.8	5.1e-15	0.02	0.04	0.96	FALSE
92	GTEx	Stomach	CEP63	0.15	0.12	lasso	8	0.11	9.1e-06	-7.96	7.8	6.0e-15	0.01	0.05	0.95	FALSE
47	GTEx	Colon Sigmoid	ANAPC13	0.43	0.32	lasso	4	0.33	2.4e-12	-8.37	7.8	9.0e-15	0.03	0.03	0.97	FALSE
110	NTR	Blood	ANAPC13	0.03	0.03	lasso	4	0.03	5.1e-09	-7.82	7.7	1.1e-14	0.02	0.04	0.96	FALSE
152	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	CEP63	0.06	0.01	blup	49	0.04	5.8e-03	-8.46	7.7	1.2e-14	0.02	0.02	0.69	FALSE
44	GTEx	Cells Transformed fibroblasts	ANAPC13	0.46	0.53	enet	35	0.54	4.0e-47	-8.37	7.7	1.3e-14	0.03	0.04	0.96	FALSE
120	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	CEP63	0.06	0.02	enet	9	0.04	1.2e-04	-8.41	7.7	1.5e-14	0.00	0.03	0.78	FALSE
22	GTEx	Artery Tibial	CEP63	0.32	0.37	lasso	7	0.38	5.7e-31	-8.41	7.7	2.0e-14	0.02	0.04	0.96	FALSE
42	GTEx	Cells EBV-transformed lymphocytes	CEP63	0.21	0.12	enet	19	0.09	6.2e-04	-8.25	7.6	2.1e-14	0.00	0.04	0.87	FALSE
61	GTEx	Esophagus Muscularis	RP11-731C17.2	0.16	0.03	enet	13	0.06	1.1e-04	-3.26	-7.6	2.5e-14	0.63	0.08	0.88	FALSE
78	GTEx	Pituitary	ANAPC13	0.36	0.16	lasso	20	0.12	5.7e-04	-8.38	7.6	2.6e-14	0.01	0.04	0.94	FALSE
123	The Cancer Genome Atlas	Colon Adenocarcinoma	ANAPC13	0.17	0.26	enet	8	0.25	2.2e-14	-8.39	7.6	2.8e-14	0.02	0.03	0.97	FALSE
133	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	STAG1	0.04	0.02	lasso	3	0.02	4.1e-03	-7.08	7.6	2.8e-14	-0.74	0.17	0.53	FALSE
157	The Cancer Genome Atlas	Rectum Adenocarcinoma	ANAPC13	0.25	0.21	lasso	2	0.22	6.8e-06	-8.39	7.5	8.6e-14	0.02	0.03	0.95	FALSE
85	GTEx	Skin Sun Exposed Lower leg	CEP63	0.19	0.25	enet	25	0.25	1.1e-20	-8.43	7.3	2.1e-13	0.02	0.03	0.97	FALSE
73	GTEx	Nerve Tibial	CEP63	0.23	0.24	lasso	10	0.27	4.1e-19	-8.39	7.3	4.0e-13	0.02	0.04	0.96	FALSE
125	The Cancer Genome Atlas	Colon Adenocarcinoma	PPP2R3A	0.14	0.06	lasso	4	0.04	2.1e-03	-7.22	-7.2	4.6e-13	0.69	0.09	0.04	FALSE
163	The Cancer Genome Atlas	Thyroid Carcinoma	ANAPC13	0.25	0.28	blup	38	0.31	3.6e-30	-8.43	7.1	1.5e-12	0.03	0.03	0.97	FALSE
9	GTEx	Adipose Subcutaneous	RP11-85F14.5	0.07	0.08	lasso	13	0.07	3.3e-06	7.06	-7.1	1.6e-12	0.17	0.96	0.03	FALSE
55	GTEx	Esophagus Mucosa	SLC35G2	0.13	0.10	lasso	10	0.09	1.3e-06	7.07	7.1	1.6e-12	-0.17	0.98	0.00	FALSE
13	GTEx	Adipose Visceral Omentum	RP11-85F14.5	0.09	0.07	lasso	3	0.04	2.4e-03	7.13	-7.0	1.8e-12	0.16	0.68	0.06	FALSE
43	GTEx	Cells EBV-transformed lymphocytes	RP11-85F14.5	0.23	0.14	lasso	19	0.12	8.4e-05	7.11	-7.0	2.2e-12	0.16	0.80	0.03	FALSE
28	GTEx	Brain Cerebellum	RP11-85F14.5	0.13	0.10	lasso	7	0.07	4.1e-03	7.07	-6.9	4.7e-12	0.21	0.52	0.09	FALSE
94	GTEx	Testis	SLC35G2	0.17	0.19	lasso	10	0.18	1.5e-08	7.13	6.9	5.2e-12	-0.22	1.00	0.00	FALSE
106	GTEx	Whole Blood	CEP63	0.10	0.05	lasso	5	0.07	1.0e-06	-8.43	6.9	5.5e-12	0.03	0.03	0.97	FALSE
51	GTEx	Esophagus Gastroesophageal Junction	CEP63	0.29	0.20	lasso	9	0.19	2.0e-07	-8.41	6.8	9.6e-12	0.02	0.03	0.97	FALSE
40	GTEx	Breast Mammary Tissue (Female)	RP11-85F14.5	0.26	0.03	lasso	3	0.06	8.6e-03	3.31	-6.8	1.3e-11	0.25	0.06	0.10	FALSE
156	The Cancer Genome Atlas	Prostate Adenocarcinoma	PCCB	0.06	0.02	lasso	2	0.03	2.3e-04	-8.40	6.7	2.8e-11	-0.72	0.38	0.17	FALSE
30	GTEx	Brain Cortex	RP11-731C17.2	0.11	0.08	lasso	3	0.09	1.6e-03	6.59	-6.6	3.1e-11	0.13	0.22	0.06	FALSE
82	GTEx	Skin Not Sun Exposed Suprapubic	CEP63	0.22	0.20	enet	29	0.24	1.1e-13	-7.88	6.6	3.5e-11	0.01	0.04	0.96	FALSE
26	GTEx	Brain Cerebellum	PPP2R3A	0.28	-0.01	enet	21	0.04	2.9e-02	-8.78	-6.5	6.5e-11	0.56	0.06	0.47	FALSE
127	The Cancer Genome Atlas	Esophageal Carcinoma	PCCB	0.15	0.03	blup	54	0.05	9.6e-03	2.98	6.5	7.7e-11	-0.69	0.02	0.40	FALSE
60	GTEx	Esophagus Muscularis	RP11-85F14.5	0.13	0.09	lasso	4	0.06	8.9e-05	7.11	-6.4	1.3e-10	0.15	0.93	0.01	FALSE
67	GTEx	Lung	RP11-85F14.5	0.07	0.05	lasso	19	0.05	8.8e-05	5.49	-6.4	1.3e-10	0.26	0.94	0.01	FALSE
34	GTEx	Breast Mammary Tissue (Male)	PCCB	0.11	0.00	lasso	6	0.01	1.8e-01	-7.26	6.3	2.4e-10	-0.49	0.04	0.26	FALSE
81	GTEx	Skin Not Sun Exposed Suprapubic	IL20RB	0.22	0.16	lasso	9	0.19	1.2e-10	-5.01	-6.3	2.5e-10	0.49	0.99	0.01	FALSE
25	GTEx	Brain Cerebellar Hemisphere	RP11-731C17.2	0.16	0.02	enet	24	0.09	3.0e-03	5.15	-6.3	3.7e-10	0.24	0.22	0.05	FALSE
144	The Cancer Genome Atlas	Lung Adenocarcinoma	CEP63	0.04	0.03	lasso	3	0.04	3.7e-05	-4.64	6.2	5.7e-10	0.04	0.03	0.96	FALSE
118	YFS	Blood	STAG1	0.08	0.02	bslmm	445	0.03	3.6e-10	2.92	6.2	7.1e-10	-0.22	0.99	0.00	FALSE
23	GTEx	Brain Caudate basal ganglia	PCCB	0.11	0.01	enet	12	0.01	2.1e-01	3.02	6.0	2.3e-09	-0.60	0.08	0.08	FALSE
84	GTEx	Skin Sun Exposed Lower leg	IL20RB	0.16	0.08	lasso	7	0.14	1.2e-11	-5.41	-6.0	2.7e-09	0.35	0.95	0.05	FALSE
66	GTEx	Lung	CEP63	0.18	0.17	enet	21	0.23	9.8e-18	-8.43	5.9	4.2e-09	0.03	0.03	0.97	FALSE
93	GTEx	Stomach	RP11-85F14.5	0.17	0.11	lasso	5	0.08	9.4e-05	7.07	-5.8	8.7e-09	0.10	0.91	0.01	FALSE
96	GTEx	Testis	RP11-731C17.2	0.10	0.03	enet	22	0.00	2.5e-01	7.16	5.7	1.1e-08	-0.26	0.12	0.08	FALSE
115	YFS	Blood	EPHB1	0.12	0.05	bslmm	754	0.10	2.8e-31	0.35	5.7	1.5e-08	0.07	1.00	0.00	FALSE
114	YFS	Blood	CEP63	0.21	0.21	enet	80	0.27	2.1e-87	-8.42	5.7	1.6e-08	0.01	0.04	0.96	FALSE
77	GTEx	Pancreas	RP11-85F14.5	0.22	0.02	enet	14	0.05	5.4e-03	7.13	-5.6	1.9e-08	0.22	0.19	0.07	FALSE
136	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	IL20RB	0.06	0.00	enet	20	0.01	8.8e-03	-5.25	-5.6	2.2e-08	0.30	0.01	0.69	FALSE
150	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	MSL2	0.09	0.01	blup	35	0.02	8.1e-03	-4.99	5.6	2.2e-08	-0.60	0.04	0.28	FALSE
31	GTEx	Breast Mammary Tissue	PCCB	0.08	0.05	lasso	3	0.03	1.3e-02	-4.92	5.6	2.8e-08	-0.52	0.29	0.06	FALSE
57	GTEx	Esophagus Mucosa	RP11-85F14.5	0.13	0.10	lasso	3	0.11	5.1e-08	5.50	-5.5	3.6e-08	0.26	1.00	0.00	FALSE
117	YFS	Blood	NCK1	0.01	0.02	enet	4	0.02	2.2e-06	5.50	-5.5	3.9e-08	0.26	0.98	0.00	FALSE
147	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	STAG1	0.05	0.00	blup	151	0.01	2.9e-02	3.26	5.4	6.7e-08	-0.62	0.71	0.14	FALSE
139	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	RYK	0.09	0.01	blup	63	0.01	4.8e-02	-4.22	-5.2	1.7e-07	-0.03	0.03	0.22	FALSE
6	GTEx	Adipose Subcutaneous	PCCB	0.07	0.05	enet	4	0.02	6.6e-03	-4.92	5.2	2.4e-07	-0.49	0.40	0.05	FALSE